Business
GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains
GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains\nEffective medicines start with quality ingredients. GB Sciences has developed controlled growth environments and methods to amplify the yield of important raw materials for its medical formulations.\nCanada NewsWire\nLAS VEGAS, Dec. 8, 2018\n\n\n\nLAS VEGAS, Dec. 8, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB: GBLX) currently markets both medical and adult use cannabis products in Nevada under the respected Cultivation Labs brand. The Company has selected and nurtured several cannabis strains that are scoring some of the highest testing lab results seen in the Nevada market, according to the chemoprofile test results from DigiPath Labs. \n\n\n \n \n\n \nBut this is only one half of the story. By maximizing the production of critical raw materials that can only be derived from the cannabis plant, GB Sciences is able to provide the base materials for their proprietary cannabis-based medical formulations. This breakthrough places cannabis-based medical formulations on a level playing field with traditional medical formulations when it comes to patient studies and clinical trials; a task that, until now, has proven extremely difficult industry-wide.\n\nJohn Poss, Chairman and CEO stated, \"Cannabis-based formulations can now move past anecdotal evidence and instead provide hard, verifiable data to prove safety and efficacy. This changes everything. This is the basis of real medicine.\"\n\nThe latest proven strain in GB Sciences' ongoing research is WiFi OG, a 60% sativa dominant hybrid. The tissue propagation unit regenerated the strain using the GB Sciences' proprietary tissue culture process to get a proper volume of test plants to facilitate research. This process not only ensures zero mold or bacteria in the mother plants, but also allows GB Sciences to create libraries of healthy strains.\n\nThe Cultivation...